Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy

Expression of androgen receptor (AR) splice variant 7 (AR-V7) has been identified as the mechanism associated with the development of castration-resistant prostate cancer (CRPC). However, a potential link between AR-V7 expression and resistance to taxanes, such as docetaxel or cabazitaxel, has not b...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Med
Main Authors: Shimizu, Yasuomi, Tamada, Satoshi, Kato, Minoru, Hirayama, Yukiyoshi, Takeyama, Yuji, Iguchi, Taro, Sadar, Marianne D., Nakatani, Tatsuya
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6262607/
https://ncbi.nlm.nih.gov/pubmed/30453546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm7110444
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares